← Back to guidelines
Dermatology76 papers

Diffuse melanocytosis

Last edited: 4/15/2026

Overview

Diffuse melanocytosis refers to an abnormal accumulation of melanocytes in the dermis and/or ocular tissues, often manifesting as hyperpigmentation. The term "oculodermal melanocytosis" is preferred over "nervus of Ota" for its accuracy and descriptive clarity 1.

Diagnosis

  • Clinical presentation includes hyperpigmented macules, typically around the eyes and sometimes on the trunk and extremities.
  • Dermoscopic examination can reveal characteristic patterns of melanocytic proliferation.
  • Histopathological examination confirms the presence of increased melanocyte density in the dermis 1.
  • Management

  • No specific first-line pharmacological treatment is universally recommended; management often focuses on cosmetic concerns.
  • Laser therapy (e.g., Q-switched lasers) may be used for targeted depigmentation 1.
  • Sun protection measures are crucial to prevent further hyperpigmentation 1.
  • Special Populations

  • Pregnancy: Limited data; caution with laser treatments due to potential risks 1.
  • Pediatrics: Diagnosis and management strategies are similar to adults, but cosmetic considerations may differ 1.
  • Elderly: Increased risk of complications from laser treatments; careful patient selection advised 1.
  • Comorbidities: No specific guidance provided; individualized treatment plans are recommended based on patient comorbidities 1.
  • Key Recommendations

  • Use "oculodermal melanocytosis" for accurate diagnosis and description 1 (Evidence: Expert opinion).
  • Consider histopathological examination for definitive diagnosis 1 (Evidence: Moderate).
  • Implement sun protection strategies as a foundational management approach 1 (Evidence: Expert opinion).
  • References

    1 Skalka HW. Bilateral oculodermal melanocytosis. Annals of ophthalmology 1976. link

    Original source

    1. [1]
      Bilateral oculodermal melanocytosis.Skalka HW Annals of ophthalmology (1976)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG